Bharat Biotech Allowed To Conduct Vaccine Trials On Children Above 12

  • 2:38
  • Published On: January 04, 2021
Cinema View
Embed

Bharat Biotech, which received emergency approval for its Covid-19 vaccine only in "clinical trial mode", is allowed to conduct its trials on children who are above the age of 12 years. The vaccine has already been used for children above 12 in the last round and has been found safe. The Hyderabad-based firm is conducting Phase 3 trials.

Advertisement

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
"A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India
February 29, 2024 3:21
'Poverty Associated With Long Covid': Dr Soumya Swaminathan
February 19, 2024 6:52
What Does Covid-19 Do To Your Lungs?
February 19, 2024 22:46
"This Was Expected": Karnataka Health Minister On JN.1 Cases In State
December 25, 2023 3:57
Maharashtra Reports 50 New COVID-19 Cases, 9 Of Them JN.1 Infections
December 25, 2023 0:46
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination